Acetylcysteine EG 200 mg, sachets:
- The active substance is acetylcysteine, corresponding to 200 mg per sachet.
- The other ingredients are aspartame (E951) - yellow-orange S (E110) - taste of lemon - sorbitol (E420).
Chronic bronchitis
- In case of chronic bronchitis (with maintenance of lung function minimum of ± 50% of the normal value), a long-term treatment with acetylcysteine is indicated to reduce the risk and severity of exacerbations.
Cystic fibrosis
- In the case of cystic fibrosis, oral treatment can supplement the treatment by aerosol because of its greater flexibility
Acute infections of the respiratory tract.
- Proposed as symptomatic treatment intended to thin the mucous secretions and mucopurulentes in affections of the upper and lower respiratory tract
a href="https://app.fagg-afmps.be/pharma-status/api/files/62bc6b2e1e5c015ab3e6c333?version=7">https://app.fagg-afmps.be/pharma-status/api/files/62bc6b2e1e5c015ab3e6c333?version=7